Placebo + Pregabalin + Pregabalin
Phase 1Completed 0 watching 0 views this week💤 Quiet
32
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Post-operative Pain
Conditions
Post-operative Pain
Trial Timeline
May 1, 2007 → Aug 1, 2009
NCT ID
NCT00583869About Placebo + Pregabalin + Pregabalin
Placebo + Pregabalin + Pregabalin is a phase 1 stage product being developed by Pfizer for Post-operative Pain. The current trial status is completed. This product is registered under clinical trial identifier NCT00583869. Target conditions include Post-operative Pain.
Hype Score Breakdown
Clinical
10
Activity
5
Company
9
Novelty
3
Community
2
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01061372 | Phase 3 | Withdrawn |
| NCT00553475 | Phase 3 | Completed |
| NCT00583869 | Phase 1 | Completed |
Competing Products
18 competing products in Post-operative Pain